FOGHORN THERAPEUTICS INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+18.3% +$5M
$-24M
Free Cash Flow↑+100.0% +$479K
$0
Investing Cash Flow↓-40.6% -$9M
$13M
Financing Cash Flow↑+14425.0% +$577K
$581K
Capex↓-100.0% -$479K
$0
Stock-Based Comp↓-9.7% -$242K
$2M
D&A↑+5.4% +$41K
$802K
SBC Allocated Expense↓-9.7% -$242K
$2M
SBC Unrecognized Cost↓-13.7% -$3M
$20M